PharmaCloud announces launch of PharmaCloud guidance

PHILADELPHIA, USA:PharmaCloud has announced the launch of PharmaCloud Guidance, a cloud-based software application that enables users to search warning letters from the US Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP). PharmaCloud Guidance is part of a suite of software for the life sciences industry that helps professionals do their jobs more easily and with less system-generated frustration.

Designed to be easy to get and easy to use, PharmaCloud Guidance enables users to search the entire FDA database of OPDP warning letters and associated promotional materials. PharmaCloud's regulatory experts have tagged each warning letter with relevant keywords, making search results more intuitive and complete. PharmaCloud Guidance improves regulatory intelligence capabilities and promotes greater adherence to promotional practices by making warning letter searches quick and easy. In keeping with the philosophy of ‘easy to get,' PharmaCloud Guidance is priced affordably compared to similar options.

As the life sciences industry faces increasing competitive and regulatory pressures, it must find and adopt better tools, but developing and deploying software across the enterprise is a major challenge. PharmaCloud addresses that issue by providing user-centric, cloud-based software specifically tailored to the needs of the industry. Available on tablets, laptops, and desktops from anywhere in the world with Internet access, PharmaCloud applications are easy to get and easy to use.